Skip to main content
Clinical Trials/NCT01314846
NCT01314846TerminatedNot Applicable

Co-culture Versus Sequential Culture System in Advanced Maternal Age.

IVI Madrid1 site in 1 country346 target enrollmentStarted: February 2009Last updated:
Conditions

Trial Snapshot

Phase
Not Applicable
Status
Terminated
Sponsor
Enrollment
346
Locations
1
Primary Endpoint
implantation rate

Study Overview

Brief Summary

Fertilization and embryo development in vivo occurs in appropriate conditions in the mammalian reproductive tract. However in assisted reproductive technology (ART) embryos and oocytes are exposed to certain factors such as temperature, O2 pressure and pH fluctuations that may affect embryo development and viability in vitro. In Preimplantation Genetic Screening program (PGS) the investigators need to culture the embryos until day 5 so the requirement of culture techniques must be optimal to produce acceptable blastocyst rates. As it has been shown before, embryo culture conditions have the potential to impact biopsied embryos and hence PGS success rates.

Nowadays the coculture system with endometrial cells could be an alternative option to improve the blastocyst rates since some publications have indicated that endometrial cells may provide trace elements and growth factors that are not present in defined culture media and reproduce physiologic conditions. Although the role of coculture in vitro fertilization (IVF) has been controversial, a recent meta-analysis has established the potential benefits of coculture system.

The aim of this study was to compare embryologic and clinical outcomes in terms of blastocyst, implantation and pregnancy rates to evaluate endometrial epithelial cell (EEC) coculture versus sequential culture system in advanced maternal age ( ≥39 years) in the PGS program.

Study Design

Study Type
Observational
Observational Model
Case Control
Time Perspective
Retrospective

Eligibility Criteria

Ages
40 Years to 47 Years (Adult)
Sex
Female
Accepts Healthy Volunteers
No

Inclusion Criteria

  • Advanced maternal age (>39) undergoing PGS cycle

Exclusion Criteria

  • Other PGS indication
  • Altered karyotype

Outcomes

Primary Outcomes

implantation rate

Time Frame: from February 2009 to December 2010

Secondary Outcomes

No secondary outcomes reported

Investigators

Sponsor
IVI Madrid
Sponsor Class
Other
Responsible Party
Principal Investigator
Principal Investigator

Fernando Bronet

PhD

IVI Madrid

Study Sites (1)

Loading locations...

Similar Trials

Co-culture and Advanced Maternal Age in... | Clinical Trial